Lifestance Health Group

LFST

Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them

Managers holding

In their latest 13F (Q3 2026)

See who

Value held

$16.7m

Combined value at quarter end

Last quarter

0 bought

1 sold or trimmed

Price at Q2 ’26 end

$10.71

+68.1% in the quarter

Prices here are quarter-end prices implied by the 13F filings. Today’s price on Yahoo Finance

Share price change by quarter

+5.3%Q4 ’24

-9.6%Q1 ’25

-22.4%Q2 ’25

+6.4%Q3 ’25

+28.0%Q4 ’25

-9.5%Q1 ’26

+68.1%Q2 ’26

Change in the quarter-end price implied by managers’ 13F filings, adjusted for stock splits. Excludes dividends.

Managers holding it, by quarter

0Q4 ’23

0Q1 ’24

0Q2 ’24

1Q3 ’24

1Q4 ’24

1Q1 ’25

1Q2 ’25

1Q3 ’25

1Q4 ’25

1Q1 ’26

1Q2 ’26

0Q3 ’26

Counts the managers on this site whose 13F for that quarter includes Lifestance Health Group.

Who holds it

Each manager’s latest 13F, sorted by how much of their portfolio it is. Changes are against their previous quarter.

Managers holding Lifestance Health Group

First Eagle Investment Management	0.0%$16.7m	$16.7m	Trimmed -2.9%	8 qtrs

Download the holders: CSV · JSON · Markdown

Directors buying and selling

Open-market trades by directors, officers and 10% holders over the last 12 months. How this works

From their Form 4 filings with the SEC. Grants, option exercises and shares sold to pay tax are left out.

Sort by

Insider purchases and sales of Lifestance Health Group
		Bought or sold				Filing
11 Sep 2026	Tpg Gp A, LLC10% owner	▼ Sold	18,409,705	$12.29	$226m	Form 4
2 Sep 2026	Paunovich VukasinChief Technology Officer	▼ Sold	42,067	$12.87	$541k	Form 4
14 Aug 2026	Deluca TeresaDirector	▼ Sold	7,500	$12.68	$95k	Form 4
13 Aug 2026	Deluca TeresaDirector	▼ Sold	20,441	$12.23	$250k	Form 4
11 Aug 2026	Burdick Kenneth ADirector	▼ Sold	500,000	$11.51	$5.8m	Form 4
10 Aug 2026	Tpg Gp A, LLC10% owner	▼ Sold	13,643,207	$10.62	$145m	Form 4
10 Aug 2026	Miller Lisa KChief Operating Officer	▼ Sold	47,912	$10.85	$520k	Form 4
10 Aug 2026	Paunovich VukasinChief Technology Officer	▼ Sold	44,394	$10.85	$482k	Form 4

About the company

Sector: Health care · Services-Health Services
Incorporated in: Delaware
Financial year ends: 31 December
Shares outstanding: 382m at 29 Jul 2026
SEC filings: Annual reports and other filings on EDGAR

Revenue and profit

$213m2019

$668m2021

$860m2022

$1.1bn2023

$1.3bn2024

$1.4bn2025

Lifestance Health Group revenue and net income by year
Year	Revenue	Net income
2025	$1.4bn	$9.7m
2024	$1.3bn	−$57.4m
2023	$1.1bn	−$186m
2022	$860m	−$216m
2021	$668m	−$307m
2019	$213m	$5.7m

From the company’s XBRL financial statements filed with the SEC, for each financial year. Gaps mean the company didn’t report that figure in a standard form.